About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries
2026 Readers' Choice Winners

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

SI-BONE, Inc. - Common Stock (NQ:SIBN)

25.52 +1.75 (+7.36%)

Delayed Quote Updated: 11:22 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SI-BONE, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

SI-BONE: Q2 Earnings Insights ↗

August 08, 2022

SI-BONE (NASDAQ:SIBN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

SI-BONE's Earnings: A Preview ↗

August 05, 2022

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that SI-BONE will report...

Via Benzinga

SI-BONE's Earnings Outlook ↗

May 06, 2022

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that SI-BONE will report...

Via Benzinga

Return on Capital Employed Insights for SI-BONE ↗

August 19, 2021

Pulled from Benzinga Pro data SI-BONE (NASDAQ:SIBN) reported Q2 sales of $22.19 million. Earnings fell to a loss of $12.96 million, resulting in a 12.01% decrease from last...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 19, 2021

Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Understanding SI-BONE's Unusual Options Activity ↗

July 30, 2021

SI-BONE (NASDAQ:SIBN) shares experienced unusual options ...

Via Benzinga

Earnings Scheduled For August 8, 2022 ↗

August 08, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Via Benzinga

SI-BONE: Q4 Earnings Insights ↗

February 28, 2022

SI-BONE (NASDAQ:SIBN) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings SI-BONE...

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Earnings Scheduled For May 9, 2022 ↗

May 09, 2022

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

Via Benzinga

SI-BONE: Q3 Earnings Insights ↗

November 08, 2021

SI-BONE (NASDAQ:SIBN) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings SI-BONE...

Via Benzinga

Earnings Scheduled For November 8, 2021 ↗

November 08, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...

Via Benzinga

Recap: SI-BONE Q1 Earnings ↗

May 03, 2021

Shares of SI-BONE (NASDAQ:SIBN) remained quited after the company reported Q1 results. Quarterly Results Earnings per share were up 21.28% year over year to ($0.37), which beat...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Return on Capital Employed Insights for SI-BONE ↗

August 12, 2021

After pulling data from Benzinga Pro it seems like during Q2, SI-BONE (NASDAQ:SIBN) brought in sales totaling $22.19 million. However, earnings decreased 12.01%, resulting in a...

Via Benzinga

75 Biggest Movers From Yesterday ↗

August 04, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 03, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...

Via Benzinga

48 Stocks Moving In Tuesday's Mid-Day Session ↗

August 03, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...

Via Benzinga

SI-BONE Q2 Sales Beat Estimates But Higher Costs Hit Profitability, Maintains FY21 Revenue Outlook ↗

August 03, 2021

SI-BONE Inc (NASDAQ: SIBN) reported Q2 sales of $22.2 million, beating the consensus of $21.96 million, representing a 58% Y/Y increase over the COVID-19 impacted 2020...

Via Benzinga

Topics Earnings

SI-BONE: Q2 Earnings Insights ↗

August 02, 2021

Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 4.55% over the past year to...

Via Benzinga

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

Earnings Scheduled For August 2, 2021 ↗

August 02, 2021

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter. • Addex Therapeutics (NASDAQ:ADXN) is...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

SI-BONE's Sacroiliac Joint Implant Show Accelerated Fusion, Reduction In Opioid Use ↗

July 08, 2021

SI-BONE Inc (NASDAQ: SIBN) has announced the publication of 2-year results from the SALLY study of the iFuse-3D Implant System. Clinical...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2021 ↗

June 08, 2021

Upgrades According to Seaport Global, the prior rating for CMC Materials Inc (NASDAQ:CCMP) was changed from Neutral to Buy. CMC Materials earned $1.71 in the second...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

May 04, 2021

Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs. Interesting Facts: The company with the largest market cap to set a new 52-week high was...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

SI-BONE, Inc. - Common Stock (NQ:SIBN)

All News about SI-BONE, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us